The Introduction of New Non-Drug Health Technologies into Canadian Healthcare Institutions: Opportunities and Challenges

3Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

INTRODUCTION: A recent pan-Canadian survey of 48 health organizations concluded that structures, processes, factors and information used to support funding decisions on new non-drug health technologies (NDTs) vary within and across jurisdictions in Canada. METHODS: A self-administered survey was used to determine demographic and financial characteristics of organizations, followed by in-depth interviews with senior leadership of consenting organizations to understand the processes for making funding decisions on NDTs. RESULTS: Seventy-three and 48 organizations completed self-administered surveys and telephone interviews, respectively (with 45 participating in both ways). Fifty-five different processes were identified, the majority of which addressed capital equipment. Most involved multidisciplinary committees (with medical and non-medical representation), but the types of information used to inform deliberations varied. Across all processes, decision-making criteria included local considerations such as alignment with organizational priorities. CONCLUSIONS: NDT decision-making processes vary in complexity, depending on characteristics of the healthcare organization and context.

Cite

CITATION STYLE

APA

Stafinski, T., Deber, R., Rhainds, M., Martin, J., Noseworthy, T., Bryan, S., & Menon, D. (2019). The Introduction of New Non-Drug Health Technologies into Canadian Healthcare Institutions: Opportunities and Challenges. Healthcare Policy = Politiques de Sante, 15(1), 95–106. https://doi.org/10.12927/hcpol.2019.25935

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free